In May 2020, we invited three US Principal Investigators to join a panel discussion and a Q&A session on what will be of most use to clinical trial sites as they continue ongoing activities or plan to restart trials in light of the COVID-19 pandemic. Our Panelists represented three different therapy areas in three different regions of the US (the mid-West, South, and West).
Overall, large pharma and small biotechs responded differently, and sites are most concerned about how to reengage with patients while complying with safe distancing practices.
Learn more in this two-part video series from Clare Grace, Vice President,
Site & Patient Access:
The Clinical Site Reactivation series is part of Syneos Health Insights Hub Live. Syneos Health Insights Hub Live uncovers unique insights and global trends discovered by experts working on the front lines of healthcare around the world. How do we change lives? Watch and learn.
